Abbott Laboratories Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-08-27
Share capital
70 147 200,00 PLN
Registered address
Postępu 21B, 02-676 Warszawa, Poland
Electronic delivery address
AE:PL-99976-42584-WDIVD-23

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 174.51mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 7.67mMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 162.79mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 149.82mMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 1998-03-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jan 17, 2011Commercial Companies Code notice
Nov 3, 2010Merger plan

Public aid

No public aid cases recorded in the last 10 years.

European Funds

StartProjectEU co-financingProgramme
2021-02-24
Procurement of rapid antigene tests for diagnostic of covid-19
$6,136,0762.2.26 - Instrument for emergency support within the Union (ESI)

Tenders

161 tenders recorded as contractor: 58 national ($6,875,437) and 103 EU ($100,999,619), and 1 as contracting authority.

Publication dateSubjectAmountContracting authority
Sep 28, 2026
Dostawa odczynników i sprzętu laboratoryjnego II
—Zespół Opieki Zdrowotnej w Oławie
Sep 24, 2026
Dostawa odczynników do wykonywania badań immunochemicznych, biochemicznych wraz z dzierżawą analizatora
—Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lubaczowie
Sep 21, 2026
Dostawa paneli syndromicznych do systemu Biofire, odczynników do oznaczania hemoglobiny glikowanej z dzierżawą aparatu, odczynników do badań immunochemicznych wraz z dzierżawą analizatorów i systemu pre/poanalitycznego, odczynników do badań endokrynologicznych z zakresu chorób metabolicznych i zakaźnych z dzierżawą analizatora oraz odczynników immunochemicznych hormonalnych z dzierżawą aparatu
—Mazowiecki Szpital Bródnowski sp. z o.o.

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Sylwia Borowska Kurek — President of the Management Board
Bradley Jay Slater — Management Board Member
Magdalena Dominika Śledziewska — Management Board Member

Manner of representation

Each of the members of the management board acting independently is authorized to represent the company, make declarations and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
221,728$5,989,411.1331.609%
St. Jude Medical Luxembourg
479,744$12,959,049.1668.391%

Beneficial owners

PersonRights
Sylwia Beata Borowska-Kurek (55)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Bradley Jay Slater (57)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Magdalena Dominika Śledziewska (48)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Bartłomiej Jacek Świeprawski (49)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

NameRevenueWebsite
Centrala Farmaceutyczna CefarmS.A.$457,052,669.59cefarm.com.pl
Servier Polska Servicessp. z o.o.$125,526,921.78servier.pl
Stada Pharmsp. z o.o.$98,071,375.86walmark.eu
ITPS.A.$55,285,362.18itpsa.pl
IMC Impomed CentrumS.A.$4,447,564.10impomed.pl
Gtm-Mobil M-T T.Walisiewiczsp. k.$3,438,533.82gtmmobil.com.pl
Reynolds Medicalsp. z o.o.$3,313,657.78reymed.pl
Petronafsp. z o.o.$2,499,010.09petronaf.com
CryoprofilS.A.$1,470,469.25cryoprofil.pl
Novisc Pharmasp. z o.o.$806,018.56novisc.com

Change history

DateEvent
2023-11-06Share capital change (22,172,800.00 PLN → 70,147,200.00 PLN)
2019-01-02Share capital change (29,500,300.00 PLN → 22,172,800.00 PLN)
2015-02-02Share capital change (34,877,900.00 PLN → 29,500,300.00 PLN)
2010-12-31Share capital change (30,084,800.00 PLN → 34,877,900.00 PLN)
2009-12-04Address change (Postępu 18a, 02-676, Warszawa → Postępu 21b, 02-676, Warszawa)

FAQ

Last updated: 2026-08-07